What tests are recommended for women with sterility?
Women with sterility fail to conceive spontaneously. Therefore, we look for the cause of the problems right at the beginning of the process, i.e. at the stage of sperm-egg contact, and supplement them with examinations of basic immunological diseases and cellular immunity tests.
We monitor:
Basic parameters - serum immunoglobulin levels, baseline blood cell counts or blood counts, and CRP - tests focused on basic markers of inflammation.
Reproductive antibodies, i.e., antibodies to sperm, ovary and zona pellucida (egg envelope) - testing looks at the reaction against reproductive antigens.
Antiphospholipid markers - a set of tests for antibodies against coagulation factors that may contribute to the formation of micro-clotting, and thus to embryo healing or miscarriage.
Autoantibodies - Antibodies to nuclear antigens (ANA) are a general marker of autoimmune diseases, anti TPO is found in thyroid involvement, anti TG is found in celiac disease.
AMH (anti-müllerian hormone) - the amount of this hormone correlates with individual ovarian reserve of eggs.
NK cell activity - we culture the patient's blood together with stimulating agents-sperm, trophoblast lineage and a non-specific potent activator and monitor the expression of CD69 sign on the surface of NK and NKT cells. High expression of activation markers after sperm or trophoblast stimulation is indicative of increased cytotoxic reactivity directed against partner/fetal antigens and may affect conception success or increase the risk of miscarriage. Also, NK and NKT cell counts in the blood may not be too high.
Cytokine production--culture the patient's blood along with stimulating agents--sperm, trophoblast line and a non-specific potent activator and monitor the amount of cytokines within the cells. The production of embryoprotective IL-4 and IL-10 is desirable; high levels of embryotoxic IFN-gamma and TNF-alpha are a sign of pro-inflammatory tuning of the organism and a risk due to pregnancy.
What examinations are recommended for women with infertility?
Women with infertility become pregnant but are unable to conceive and give birth to a viable fetus. In this group, it is necessary to investigate more thoroughly whether tolerance to the fetus has been induced at all or whether there is a risk of blockage of the vessels by the microthrombi. Similarly, women who have been pregnant but have had pre-eclampsia or HELP syndrome should be investigated.
Baseline parameters, i.e. serum immunoglobulin levels, baseline blood cell counts or blood counts, CRP - testing for baseline markers of inflammation.
T regulatory cell counts - cells that induce tolerance to the fetus.
Antiphospholipid markers - a set of tests for antibodies to coagulation factors that may contribute to microclotting and thus to embryo healing or miscarriage due to inadequate fetal nutrition.
Autoantibodies - antibodies against nuclear antigens (ANA) are a general feature of autoimmune diseases, ENA antibodies are risky in terms of fetal development, anti TPO occurs in thyroid involvement, anti TG occurs in celiac disease.
AMH (anti-müllerian hormone) - the amount of this hormone correlates with individual ovarian reserve of eggs.
NK cell activity - we culture the patient's blood together with stimulating agents-sperm, trophoblast lineage and a non-specific potent activator and monitor the expression of CD69 sign on the surface of NK and NKT cells. High expression of activation markers after sperm or trophoblast stimulation is indicative of increased cytotoxic reactivity directed against partner/fetal antigens and may affect conception success or increase the risk of miscarriage.
Cytokine production - culture the patient's blood along with the stimulating agents-sperm, trophoblast line, and a nonspecific potent activator-and monitor the amount of cytokines within the cells. The production of embryoprotective IL-4 and IL-10 is desirable; high levels of embryotoxic IFN-gamma and TNF-alpha are a sign of pro-inflammatory tuning of the organism.
What tests are recommended for women with repeated unsuccessful IVF cycles?
For these women, as a rule, an infertility panel is offered. It is essential to consider what type of IVF treatment has been used in the past, whether embryos have not developed, or if the problem was only discovered when they implanted in the uterus.)
As part of a comprehensive view of the issue, it is essential that the man also undergoes the examination. For him, we focus on sperm analysis.